T 1773/16 (Dimethyl fumarate or Monomethyl fumarate for treatment of multiple sclerosis/BIOGEN) of 20.01.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T177316.20220120
- Date of decision
- 20 January 2022
- Case number
- T 1773/16
- Online on
- 3 June 2022
- Petition for review of
- -
- Application number
- 08725256.5
- IPC class
- A61K 45/06A61K 31/197A61K 31/225A61K 31/4704A61K 31/436A61K 31/7076G01N 33/50A61K 31/194A61K 38/21A61K 31/137A61K 31/277
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions and Uses for Treating Multiple Sclerosis
- Applicant name
- Biogen MA Inc.
- Opponent name
- Zentiva k.s.
Hexal AG
G. L. Pharma GmbH
European Oppositions Limited
Generics [UK] Limited
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Gallafent, Antony Xavier
Actavis Group PTC ehf (opposition withdrawn)
Synthon B.V.
Forward Pharma A/S (opposition withdrawn) - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Amendments - allowable (no)
Late-filed main request - admitted (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.